Identification of combinations of somatic mutations that predict cancer survival and immunotherapy benefit

4Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cancer evolves through the accumulation of somatic mutations over time. Although several methods have been developed to characterize mutational processes in cancers, these have not been specifically designed to identify mutational patterns that predict patient prognosis. Here we present CLICnet, a method that utilizes mutational data to cluster patients by survival rate. CLICnet employs Restricted Boltzmann Machines, a type of generative neural network, which allows for the capture of complex mutational patterns associated with patient survival in different cancer types. For some cancer types, clustering produced by CLICnet also predicts benefit from anti-PD1 immune checkpoint blockade therapy, whereas for other cancer types, the mutational processes associated with survival are different from those associated with the improved anti-PD1 survival benefit. Thus, CLICnet has the ability to systematically identify and catalogue combinations of mutations that predict cancer survival, unveiling intricate associations between mutations, survival, and immunotherapy benefit.

References Powered by Scopus

Hallmarks of cancer: The next generation

51859Citations
N/AReaders
Get full text

Reducing the dimensionality of data with neural networks

17223Citations
N/AReaders
Get full text

The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data

12397Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Prediction uncertainty estimates elucidate the limitation of current NSCLC subtype classification in representing mutational heterogeneity

2Citations
N/AReaders
Get full text

Computational Methods Summarizing Mutational Patterns in Cancer: Promise and Limitations for Clinical Applications

2Citations
N/AReaders
Get full text

Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gussow, A. B., Koonin, E. V., & Auslander, N. (2021). Identification of combinations of somatic mutations that predict cancer survival and immunotherapy benefit. NAR Cancer, 3(2). https://doi.org/10.1093/narcan/zcab017

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

100%

Readers' Discipline

Tooltip

Computer Science 2

33%

Agricultural and Biological Sciences 2

33%

Arts and Humanities 1

17%

Biochemistry, Genetics and Molecular Bi... 1

17%

Save time finding and organizing research with Mendeley

Sign up for free